Business
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026
NEW YORK, March 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally
About this update from Baird Medical Investment Holdings Ltd
[{"type":"text","content":"NEW YORK, March 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (\"Baird Medical\" or the \"Company\"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful strategic showcase at the 2026 North American Society for Interventional Thyroidology (NASIT) in Portland, Oregon. This engagement advances the Company's goal to expand patient access to advanced, minimally invasive treatment options.\n \n \n \n \n \n \n \nBaird Medical's proprietary MWA platforms garnered significant interest during the event's thermal ablation workshop and at the Company's dedicated exhibit. Leadership facilitated targeted discussions with established Key Opinion Leaders (KOLs) and emerging physicians, exchanging critical insights on the clinical applications of MWA technology. Through these interactions, the Company showcased how integrating precision, non-surgical interventions into modern treatment paradigms can elevate the standard of patient care.\"Our robust presence at NASIT directly advances our mission to elevate the standard of care across the United States,\" stated Mark Saxton, U.S. CEO of Baird Medical. \"By connecting with established pioneers and new specialists at the forefront of thermal ablation, we are accelerating the adoption of precision therapies and empowering providers to deliver superior, minimally invasive outcomes.\"About Baird Medical Baird Medical is a forward-thinking medical device company specializing in minimally invasive diagnostics and treatment. It is dedicated to the research and development of surgical robotic systems and innovative minimally invasive surgical instruments. Our mission is to enhance patient outcomes through precision technology and advanced diagnostic solutions. The company will foster strategic collaborations with leading academic institutions. Our vision extends beyond surgical assistance, aiming to develop intelligent systems that proactively guide diagnostic decisions and preventive healthcare strategies. As an FDA 510(k)-certified medical device company, Baird Medical's solutions have been used in over 30 prestigious hospitals and clinics across the United States, including Mayo Clinic, Tulane Medical Center, Columbia University Medical Center, UCSF Medical Center, Weill Cornell Medical Center, and The George Washin...